Skip to content

Clinical trials

Phase 3 Uterine Cervical Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 3 Clear all

183 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20029
20036
20044
20051
20069
200710
20089
200914
20103
201111
20126
20131
20143
20159
20163
20174
20187
20194
202011
202114
202211
20233
20248
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93
Unknown status37
Recruiting19
Active, not recruiting11
Terminated11
Not yet recruiting6
Withdrawn5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline19
Merck Sharp & Dohme LLC16
Gynecologic Oncology Group7
Shanghai Bovax Biotechnology Co., Ltd.6
Sun Yat-sen University6
Tata Memorial Hospital5
M.D. Anderson Cancer Center4
Xiamen University4
Chang Gung Memorial Hospital3
European Organisation for Research and Treatment of Cancer - EORTC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms183
Papillomavirus Infections30
Condylomata Acuminata22
Vaginal Neoplasms18
Vulvar Neoplasms16
Endometrial Neoplasms14
Uterine Cervical Dysplasia14
Neoplasms10
Ovarian Neoplasms9
Anus Neoplasms5

Trials

Showing 76 to 100 of 183. Each trial links to its page on Pharma Observatory.

83 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.